SEC Form D private-offering filing

Nacuity Pharmaceuticals, Inc.

Name: Nacuity Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Fort Worth, TX
Published: 2025-12-30

A new SEC Form D private-offering notice from Fort Worth, TX, a $30,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Nacuity Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Clinical stage pharmaceutical company developing therapies targeting oxidative stress for eye diseases like retinitis pigmentosa and cataract, plus other chronic conditions

Filed 2025-12-30Filed to raise $30,000,000First money in 2025-12-11Raised so far $8,393,350HQ (as filed) Fort Worth, TXSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified nacuity.com↗Named in the filing 10 executives & directors

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.